Mato
ShowsHow it worksAI talentsFree toolsPricing
Book a demo
ShowsHow it worksAI talentsFree toolsPricingSign in
Mato
Mato

The first generation of AI talents. Live AI media for brands, networks and creators.

ElevenLabs GrantsAWS ActivateGoogle for StartupsNVIDIA Inception Program

Product

  • How it works
  • AI talents
  • Documentation
  • The studio
  • Pricing
  • Embed player
  • Mato MCP
  • Mato Voice
  • Voice Studio
  • Changelog

Company

  • About
  • Vision
  • Partners
  • Affiliates
  • Blog
  • CustomersComing soon
  • CareersComing soon
  • Press kit
  • Contact

Resources

  • Investor overview
  • Free podcast tools
  • Free podcast transcription
  • Podcast ROI calculator
  • API docsComing soon
  • SecurityComing soon
  • StatusComing soon

© 2026 Mato. All rights reserved.

English · Multiple languages available

PrivacyTerms

Live Interview

And why does that matter?

This is how a Mato agent talks. Take the other seat: answer a few and feel it follow the thread.

Try it yourself

Podcast charts

Master One Thing - Rapamycin Longevity Series

Published by Krister Kauppi

  • Health & fitness
  • Nutrition
  • Science
  • Life sciences

Rapamycin longevity series is about increasing our knowledge about this longevity compound together with scientists, physicians and other experts.

Listen on Apple Podcasts, opens in a new tabMake something like it

On the charts

1 chart placement

Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.

  1. Number 142Life sciencesUnited Kingdom

From the feed

Recent episodes

The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.

  1. Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

    Jan 17, 2024

    Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics. Links https://www.tornado-tx.com Joan's LinkedIn Joan’s research publications Big thanks to TimePie for the research help for this episode Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on: Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  2. Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

    Oct 17, 2023

    Professor Brian Kennedy from the National University of Singapore is one of the world's leading researchers in the longevity field and has done longevity research for more than two decades. He is active in many different longevity companies and has been the President and CEO at Buck Institute for Research on Aging. Throughout the years he has made many different important and revolutionary longevity discoveries. Currently he is also one of the persons who is trying to move the longevity forward in a much efficient and faster way. This work he is doing in Singapore where he is leading a huge longevity research project. This unique project is something we are going to talk about in the podcast. We will also talk about his research on Rapamycin and other interesting longevity topics. Links The centre for Healthy Longevity at the National University of Singapore Healthy Longevity webinars on Youtube Brian's research publications Brian's Twitter Brian's LinkedIn Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on: Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  3. Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases

    Aug 22, 2023

    The world's leading Rapamycin researcher Mikhail Blagosklonny has a long background in cancer research and one important discovery he made around 2000 was that Rapamycin slowed down senescent cancer cells in different ways. After that step by step his interest in the longevity field increased and he developed the very interesting hyperfunction theory of aging. He has made a huge contribution in moving the Rapamycin longevity field forward and his research papers have impacted many people. For example, the Rapamycin physician Alan Green who thanks to these papers took the decision in 2017 to start prescribing Rapamycin off label. Today Alan Green has the biggest clinical experience in the area with more than 1200 patients. A lot of other physicians have after that also taken these steps and one of those are for example physician Peter Attia. Links Mikhail's research publications Mikhail's twitter Homepage Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on: Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  4. Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life

    Jul 11, 2023

    Dr Brad Stanfield works as a medical doctor in New Zealand and beside his work in primary-care he has his own Youtube channel, in which he goes through the latest research and clinical guidelines on preventative medicine and longevity. In today’s podcast we are going to talk about Brad’s upcoming Rapamycin trial, the importance of muscle when we get older, sarcopenia and lots of other interesting longevity topics. Links Brad Stanfield's Youtube Donate to Brad's Rapamycin clinical trial Brad's MicroVitamin supplement Brad's twitter Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  5. Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all

    Jun 14, 2023

    Professor Pankaj Kapahi has his own lab at the Buck Institute for Research on Aging. His research for two decades has been focusing on things such as dietary restriction, fasting, rapamycin, nutrition and longevity. Pankaj was one of the pioneer researchers who discovered in the beginning of 2000 that genetic inhibition of mTOR led to life extension in flies. In this podcast we are going to talk about that discovery, Rapamycin, calorie restriction and other interesting longevity topics. Links Kapahi's Lab at Buck Institute Juvify and GLYLO Pankaj's twitter Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on: Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  6. Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research

    May 15, 2023

    Professor Matt Kaeberlein from the University of Washington is one of the world's leading researchers in the Rapamycin field. He has done Rapamycin research on multiple species for two decades. Everything from yeasts, worms, mice and now also dogs and humans. Matt has made a big contribution to the longevity field and in this podcast he will share the knowledge he has acquired in the field. Links The Dog Aging Project (possible to still apply) Ora Biomedical Optispan Matt's twitter Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  7. Alan Green on Rapamycin Longevity Series | Lessons learned from over 1200 patients

    Apr 11, 2023

    Dr Alan Green has his own medical practice in New York which focuses on longevity. He is a Rapamycin pioneer and one of the important longevity leaders who has made a big contribution to the longevity field and especially regarding the compound Rapamycin. Today he has clinical experience of more than 1200 patients who take Rapamycin and in this podcast he will share the knowledge he has acquired in the field. Contact information for Dr Alan Green's medical practice can be found here https://rapamycintherapy.com Rapamycin resources Rapamycin.news Rapamycin Facebook group Rapamycin Reddit group Connect with Krister on Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

  8. Ross Pelton on Rapamycin Longevity Series | How it all began

    Mar 15, 2023

    Ross Pelton has a background as a pharmacist and is an author of 12 books in the health field. In this podcast we are going to talk about his recent published book "Rapamycin, mTOR, Autophagy & Treating mTOR Syndrome". The purpose of this podcast is to increase our knowledge about Rapamycin and it's longevity effects. His book can be found on https://www.lifeextension.com/rapa Or call (866) 598-6747 24 hours a day to order the book and get a free 6-month subscription to Life Extension magazine Ross Pelton's homepage https://www.naturalpharmacist.net Links from the podcast - The Dog Aging Project https://dogagingproject.org - Ross Pelton's paper "The Microbiome Theory of Aging" http://imjournal.com/oa/index.html?fid=Microbiome_Theory_of_Aging - Free book about Dr. Ohhira's Probiotics & Postbiotic Metabolites https://naturalpharmacist.net/ohhirabook Connect with Krister on Twitter LinkedIn Instagram Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

Ranking source

Apple Podcasts rankings via the Mato Topic Intelligence Platform.

Observed September 20, 2026.

Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.

Pairs with

What to do with a chart

01ShowsThe shows Mato publishesEvery public Mato show, its episodes, and the Apple placements it holds.02AI talentPick the voice before the formatThe live roster of hosts, each with samples you can listen to before you commit.03How it worksFrom an idea to a published episodeWhat Mato does between the brief and the feed, step by step.

Steal the structure, not the show

Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.

Hear a Mato showCreate a show inspired by this